FDA Approves Medtronic’s Micra Leadless Pacemaker With Large Post-Market Trial Condition

The US FDA approved Medtronic’s Micra transcatheter leadless single-chamber pacemaker on April 6, beating out St. Jude’s Nanostim to be the first transcatheter leadless pacemaker to earn FDA approval.